What cardiovascular risk has been suggested by some studies of the abacavir component of Triumeq?

Some studies suggest that abacavir, a component of Triumeq, increases the risk of cardiovascular events, notably myocardial infarction (heart attack), although clinical and observational study results are inconsistent.